- Home
- Publications
- Publication Search
- Publication Details
Title
A novel treatment for glioblastoma: integrin inhibition
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 12, Issue 4, Pages 421-435
Publisher
Informa UK Limited
Online
2012-03-26
DOI
10.1586/ern.11.188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
- (2011) Carlos Mas-Moruno et al. Anti-Cancer Agents in Medicinal Chemistry
- Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
- (2011) David A Reardon et al. Future Oncology
- Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
- (2011) W. B. Pope et al. NEUROLOGY
- Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
- (2011) Olivier Keunen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
- (2011) Philip Schmalz et al. Cancers
- Bevacizumab does not increase the risk of remote relapse in malignant glioma
- (2010) Antje Wick et al. ANNALS OF NEUROLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Change in Pattern of Relapse After Antiangiogenic Therapy in High-Grade Glioma
- (2010) Ashwatha Narayana et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
- (2010) Roger Stupp et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiographic patterns of relapse in glioblastoma
- (2010) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- NFKBIADeletion in Glioblastomas
- (2010) Markus Bredel et al. NEW ENGLAND JOURNAL OF MEDICINE
- v 3/ v 5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
- (2009) N. Skuli et al. CANCER RESEARCH
- Treatment options for recurrent glioblastoma: pitfalls and future trends
- (2009) Enrico Franceschi et al. Expert Review of Anticancer Therapy
- Genetic and cell biological analysis of integrin outside-in signaling
- (2009) K. R. Legate et al. GENES & DEVELOPMENT
- Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
- (2009) Zhizhong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The biomechanical integrin
- (2009) Erin L. Baker et al. JOURNAL OF BIOMECHANICS
- Gastrosplenic Fistula From Hodgkin's Lymphoma
- (2009) Carolyn D. Seib et al. JOURNAL OF CLINICAL ONCOLOGY
- Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
- (2009) Stuart A. Grossman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Rechallenge with temozolomide in patients with recurrent gliomas
- (2009) Antje Wick et al. JOURNAL OF NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- Integrins as “functional hubs” in the regulation of pathological angiogenesis
- (2009) Liangru Contois et al. SEMINARS IN CANCER BIOLOGY
- Expression of Integrin αvβ3in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
- (2008) Oliver Schnell et al. BRAIN PATHOLOGY
- Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds 5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
- (2008) A. D. Ricart et al. CLINICAL CANCER RESEARCH
- Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency
- (2008) Tom Mikkelsen et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012
- (2008) Tobey J. MacDonald et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started